Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02038998

Randomized Study Comparing Periodic Acceleration Versus Static Position in Cerebrovascular Stroke Patients

Unicentric, Phase II, Randomized Study Comparing Periodic Acceleration Versus Static Position in Cerebrovascular Stroke Patients

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Fundacion Rioja Salud · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Stroke is one of the leading causes of death and disability worldwide. More than 85% of strokes are due to blood vessel occlusion resulting in partial destruction of the brain parenchyma. Current protocols try to re-establish blood circulation as soon as possible through chemical and/or mechanical interventions but new strategies are needed. Periodic acceleration (pGz) is a non-invasive method consisting in the application of a rocking movement to the patient that ultimately will induce the release of beneficial chemicals from the vascular endothelium (the cells lining the inside of the blood vessels). Application of pGz in an animal model of stroke resulted in a dramatic reduction of associated brain damage. This trial will investigate whether stroke patients exposed to pGz experiment significantly higher recovery than patients that remained static during their treatment.

Detailed description

Periodic acceleration (pGz) is a non-invasive method consisting in the application of a rocking movement to the patient that ultimately will induce the release of beneficial chemicals from the vascular endothelium (the cells lining the inside of the blood vessels). Application of pGz in an animal model of stroke resulted in a dramatic reduction of associated brain damage. This trial will investigate whether stroke patients exposed to pGz experiment significantly higher recovery than patients that remained static during their treatment.

Conditions

Interventions

TypeNameDescription
DEVICEExer-Rest® TLExer-Rest® TL is a therapeutic motorized platform that allows the application of pGz forces to a patient. The typical application would provide an acceleration of 0.4 Gz.

Timeline

Start date
2015-01-01
Primary completion
2022-05-01
Completion
2022-06-01
First posted
2014-01-17
Last updated
2023-02-15

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT02038998. Inclusion in this directory is not an endorsement.